JNJ vs UNH
Johnson & Johnson vs UnitedHealth Group Incorporated · Updated Mar 28, 2026
JNJ — 14 winsUNH — 9 wins
Price Performance
JNJ +46.88%UNH -49.81%
Performance
| JNJ | UNH | |
|---|---|---|
| 1 Month | -1.52% | -9.70% |
| 3 Months | +15.40% | -20.99% |
| 6 Months | +34.91% | -27.05% |
| YTD | +15.86% | -22.26% |
| 1 Year | +48.27% | -50.02% |
| 3 Year | +45.35% | -50.73% |
| 5 Year | +67.20% | -15.25% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +16.0% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| UNH | -23.0% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
Valuation
| JNJ | UNH | |
|---|---|---|
| P/E Ratio | 21.72 | 19.44 |
| Forward P/E | 20.58 | 15.92 |
| PEG Ratio | 2.47 | 1.95 |
| P/S Ratio | 6.02 | 0.56 |
| P/B Ratio | 6.96 | 2.50 |
| EV/EBITDA | 14.78 | 13.19 |
Financials
| JNJ | UNH | |
|---|---|---|
| EPS (TTM) | $11.04 | $13.20 |
| Gross Margin | +67.56% | +88.80% |
| Operating Margin | +20.22% | +0.34% |
| Net Margin | +20.83% | +0.19% |
| ROE | +32.87% | +12.80% |
| ROA | +13.46% | +4.14% |
| Debt/Equity | 0.51 | 0.78 |
Growth
| JNJ | UNH | |
|---|---|---|
| Revenue Growth YoY | +9.08% | +12.31% |
| Revenue Growth QoQ | +2.38% | +0.05% |
| EPS Growth YoY | +48.23% | -99.67% |
| EPS Growth QoQ | -1.42% | -99.23% |
Technical
| JNJ | UNH | |
|---|---|---|
| RSI (14) | 49.94 | 32.10 |
| % From 20-Day SMA | -0.41% | -8.73% |
| % From 50-Day SMA | +1.21% | -12.20% |
| % From 200-Day SMA | +21.93% | -18.14% |
| % From 52-Week High | -4.74% | -57.68% |
| % From 52-Week Low | +69.46% | +9.39% |
Analyst Ratings
JNJ
Buy(37 analysts)
Strong SellHoldStrong Buy
Price Target
$228.73
-2.73% upside
UNH
Buy(25 analysts)
Strong SellHoldStrong Buy
Price Target
$385.38
+38.68% upside
Overview
| JNJ | UNH | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $567.22B | $250.15B |
| Shares Outstanding | 2.41B | 907.7M |
| Avg Volume (10D) | 7.97M | 9.93M |
| Dividend Yield | 2.21% | 3.21% |
Frequently Asked Questions
Is JNJ or UNH a better buy right now?
Based on 23 comparable metrics, JNJ leads in 14 categories while UNH leads in 9. JNJ has a consensus analyst rating with 37 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or UNH?
Over the past year, JNJ returned +48.27% compared to UNH's -50.02%. In the short term (1 month), JNJ returned -1.52% vs UNH's -9.70%.
Is JNJ or UNH more expensive?
JNJ trades at a P/E of 21.72 compared to UNH's 19.44. On a price-to-sales basis, JNJ trades at 6.02x vs UNH's 0.56x. Forward P/E: JNJ at 20.58 vs UNH at 15.92.
Which stock has higher growth, JNJ or UNH?
JNJ's revenue grew +9.08% year-over-year compared to UNH's +12.31%. EPS growth: JNJ at +48.23% vs UNH at -99.67%.
Do JNJ and UNH pay dividends?
JNJ pays a dividend with a yield of 2.21%. UNH pays a dividend with a yield of 3.21%.
Which stock do analysts prefer, JNJ or UNH?
JNJ has 37 analysts with a target price of $228.73 (-2.73% upside). UNH has 25 analysts with a target of $385.38 (+38.68% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.